Skip to Main Content
Table 1—

Baseline characteristics of the people randomized and receiving treatment

IDet12hIDetmorn+bedNPH
n 137 139 132 
Age (years) 40.9 ± 13.0 41.3 ± 11.4 38.3 ± 12.4 
Sex (M/F) 71/66 79/60 70/62 
Weight (kg) 74.2 ± 12.6 75.0 ± 12.3 75.5 ± 14.0 
BMI (kg/m225.1 ± 3.3 25.2 ± 3.6 25.2 ± 3.7 
Diabetes duration (years) 17.1 ± 10.6 17.6 ± 10.7 15.1 ± 10.6 
FPG (mmol/l) 11.57 ± 4.65 11.65 ± 4.61 12.20 ± 5.49 
HbA1c 8.55 ± 1.20 8.74 ± 1.20 8.52 ± 1.19 
Insulin dose (units/day)*    
 Basal 26.4 ± 10.8 28.1 ± 12.5 29.5 ± 13.7 
 Mealtime 30.9 ± 12.9 29.4 ± 13.4 30.5 ± 13.4 
IDet12hIDetmorn+bedNPH
n 137 139 132 
Age (years) 40.9 ± 13.0 41.3 ± 11.4 38.3 ± 12.4 
Sex (M/F) 71/66 79/60 70/62 
Weight (kg) 74.2 ± 12.6 75.0 ± 12.3 75.5 ± 14.0 
BMI (kg/m225.1 ± 3.3 25.2 ± 3.6 25.2 ± 3.7 
Diabetes duration (years) 17.1 ± 10.6 17.6 ± 10.7 15.1 ± 10.6 
FPG (mmol/l) 11.57 ± 4.65 11.65 ± 4.61 12.20 ± 5.49 
HbA1c 8.55 ± 1.20 8.74 ± 1.20 8.52 ± 1.19 
Insulin dose (units/day)*    
 Basal 26.4 ± 10.8 28.1 ± 12.5 29.5 ± 13.7 
 Mealtime 30.9 ± 12.9 29.4 ± 13.4 30.5 ± 13.4 

Data are means ± SD.

*

Does not include people using premix insulin at study start.

Close Modal

or Create an Account

Close Modal
Close Modal